Fox Caroline S, Coady Sean, Sorlie Paul D, Levy Daniel, Meigs James B, D'Agostino Ralph B, Wilson Peter W F, Savage Peter J
National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Mass 01702-5827, USA.
JAMA. 2004 Nov 24;292(20):2495-9. doi: 10.1001/jama.292.20.2495.
Despite reductions in cardiovascular disease (CVD) mortality over the past few decades, it is unclear whether adults with and without diabetes have experienced similar declines in CVD risk.
To determine whether adults with and without diabetes experienced similar declines in incident CVD in 1950-1995.
DESIGN, SETTING, AND PARTICIPANTS: Participants aged 45-64 years from the Framingham Heart Study original and offspring cohorts who attended examinations in 1950-1966 ("earlier" time period; 4118 participants, 113 with diabetes) and 1977-1995 ("later" time period; 4063 participants, 317 with diabetes). Incidence rates of CVD among those with and without diabetes were compared between the earlier and later periods.
Myocardial infarction, coronary heart disease death, and stroke.
Among participants with diabetes, the age- and sex-adjusted CVD incidence rate was 286.4 per 10,000 person-years in the earlier period and 146.9 per 10,000 in the later period, a 49.3% (95% confidence interval [CI], 16.7%-69.4%) decline. Among participants without diabetes, the age- and sex-adjusted incidence rate was 84.6 per 10,000 person-years in the earlier period and 54.3 per 10,000 person-years in the later period, a 35.4% (95% CI, 25.3%-45.4%) decline. Hazard ratios for diabetes as a predictor of incident CVD were not different in the earlier vs later periods.
We report a 50% reduction in the rate of incident CVD events among adults with diabetes, although the absolute risk of CVD is 2-fold greater than among persons without diabetes. Adults with and without diabetes have benefited similarly during the decline in CVD rates over the last several decades. More aggressive treatment of CVD risk factors and further research on diabetes-specific factors contributing to CVD risk are needed to further reduce the high absolute risk of CVD still experienced by persons with diabetes.
尽管在过去几十年中心血管疾病(CVD)死亡率有所下降,但尚不清楚患有和未患糖尿病的成年人在CVD风险方面是否经历了类似程度的下降。
确定在1950 - 1995年期间,患有和未患糖尿病的成年人在新发CVD方面是否经历了类似程度的下降。
设计、地点和参与者:来自弗雷明汉心脏研究初始队列和后代队列的45 - 64岁参与者,他们分别在1950 - 1966年(“早期”时间段;4118名参与者,113名患有糖尿病)和1977 - 1995年(“后期”时间段;4063名参与者,317名患有糖尿病)参加了检查。比较了早期和后期患有和未患糖尿病者的CVD发病率。
心肌梗死、冠心病死亡和中风。
在患有糖尿病的参与者中,年龄和性别调整后的CVD发病率在早期为每10000人年286.4例,在后期为每10000人年146.9例,下降了49.3%(95%置信区间[CI],16.7% - 69.4%)。在未患糖尿病的参与者中,年龄和性别调整后的发病率在早期为每10000人年84.6例,在后期为每10000人年54.3例,下降了35.4%(95% CI,25.3% - 45.4%)。糖尿病作为新发CVD预测因素的风险比在早期和后期没有差异。
我们报告患有糖尿病的成年人中,新发CVD事件发生率降低了50%,尽管CVD的绝对风险比未患糖尿病者高2倍。在过去几十年CVD发病率下降期间,患有和未患糖尿病的成年人都同样从中受益。需要更积极地治疗CVD危险因素,并进一步研究导致CVD风险的糖尿病特异性因素,以进一步降低糖尿病患者仍然面临的较高CVD绝对风险。